Скачать или смотреть PI Industries Q3 FY26 Concall: CSM Strength and Pharma Integration

PI Industries Q3 FY26 Concall: CSM Strength and Pharma Integration

PI Industries delivered a robust performance in Q3 FY26, driven by sustained momentum in its Custom Synthesis and Manufacturing (CSM) export business. Management highlighted the strong order intake and the successful integration of its recent pharmaceutical acquisitions, which are diversifying the revenue base beyond agrochemicals. While the Revenue, EBITDA, and PAT figures were largely in line with brokerage and analyst estimates, the discussion focused on the company’s R&D pipeline and the strategic expansion into new chemistries and high-growth biologicals to future-proof its global supply chain position.

This video is part of our    • Conference Call   playlist. Watch the full playlist for more similar updates.

pi industries, concall, agrochemicals, csm, pharmaceuticals, manufacturing, q3 fy26, brokerage estimates, exports, r&d

#piindustries #q3fy26 #agrochemicals #concall

For daily market & company news explained in detail, Subscribe to our second channel 👉    / @baazarbuzz